Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

National Surveillance for Clostridioides difficile Infection, Sweden, 2009-2016.

Rizzardi K, Norén T, Aspevall O, Mäkitalo B, Toepfer M, Johansson Å, Åkerlund T.

Emerg Infect Dis. 2018 Sep;24(9):1617-1625. doi: 10.3201/eid2409.171658.

2.

Emergence and spread of moxifloxacin-resistant Clostridium difficile ribotype 231 in Sweden between 2006 and 2015.

Harvala H, Alm E, Åkerlund T, Rizzardi K.

New Microbes New Infect. 2016 Sep 16;14:58-66. eCollection 2016 Nov.

3.

Survey of Clostridium difficile infection surveillance systems in Europe, 2011.

Kola A, Wiuff C, Akerlund T, van Benthem BH, Coignard B, Lyytikäinen O, Weitzel-Kage D, Suetens C, Wilcox MH, Kuijper EJ, Gastmeier P; members of ECDIS-Net.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30291.

4.

High Molecular Weight Typing with MALDI-TOF MS - A Novel Method for Rapid Typing of Clostridium difficile.

Rizzardi K, Åkerlund T.

PLoS One. 2015 Apr 29;10(4):e0122457. doi: 10.1371/journal.pone.0122457. eCollection 2015.

5.

Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County.

Magnusson C, Wullt M, Löfgren S, Iveroth P, Akerlund T, Matussek A.

APMIS. 2013 Feb;121(2):153-7. doi: 10.1111/j.1600-0463.2012.02950.x. Epub 2012 Jul 25.

6.

IgG antibody response to toxins A and B in patients with Clostridium difficile infection.

Wullt M, Norén T, Ljungh A, Åkerlund T.

Clin Vaccine Immunol. 2012 Sep;19(9):1552-4. doi: 10.1128/CVI.00210-12. Epub 2012 Jul 11.

7.

Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009.

Akerlund T, Alefjord I, Dohnhammar U, Struwe J, Noren T, Tegmark-Wisell K; Swedish C. difficile Study Group.

Euro Surveill. 2011 Mar 10;16(10). pii: 19813.

8.

Comparison of strain typing results for Clostridium difficile isolates from North America.

Tenover FC, Akerlund T, Gerding DN, Goering RV, Boström T, Jonsson AM, Wong E, Wortman AT, Persing DH.

J Clin Microbiol. 2011 May;49(5):1831-7. doi: 10.1128/JCM.02446-10. Epub 2011 Mar 9.

9.

Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard.

Norén T, Alriksson I, Andersson J, Akerlund T, Unemo M.

J Clin Microbiol. 2011 Feb;49(2):710-1. doi: 10.1128/JCM.01824-10. Epub 2010 Nov 24.

10.

Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH.

J Clin Microbiol. 2010 Oct;48(10):3719-24. doi: 10.1128/JCM.00427-10. Epub 2010 Aug 11.

11.

In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden.

Norén T, Alriksson I, Akerlund T, Burman LG, Unemo M.

Clin Microbiol Infect. 2010 Aug;16(8):1104-10. doi: 10.1111/j.1469-0691.2009.03048.x. Epub 2009 Sep 3.

12.

Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism.

Karlsson S, Burman LG, Akerlund T.

Microbiology. 2008 Nov;154(Pt 11):3430-6. doi: 10.1099/mic.0.2008/019778-0.

PMID:
18957596
13.

Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.

Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, Drudy D, Fitzpatrick F, Wiuff C, Brown DJ, Coia JE, Pituch H, Reichert P, Even J, Mossong J, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E, Bouza E, Marin M, Akerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B, Rooney P, Poxton IR, Monnet DL.

Euro Surveill. 2008 Jul 31;13(31). pii: 18942.

14.

Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.

Akerlund T, Persson I, Unemo M, Norén T, Svenungsson B, Wullt M, Burman LG.

J Clin Microbiol. 2008 Apr;46(4):1530-3. doi: 10.1128/JCM.01964-07. Epub 2008 Feb 20.

15.

Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe.

Kuijper EJ, Coignard B, Brazier JS, Suetens C, Drudy D, Wiuff C, Pituch H, Reichert P, Schneider F, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Barbut F, Delmée M, Wilcox M, Pearson A, Patel BC, Brown DJ, Frei R, Akerlund T, Poxton IR, Tüll P.

Euro Surveill. 2007 Jun 1;12(6):E1-2.

PMID:
17991399
16.

Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile.

Norén T, Akerlund T, Wullt M, Burman LG, Unemo M.

Antimicrob Agents Chemother. 2007 May;51(5):1840-3. Epub 2007 Feb 16.

17.

Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Norén T, Wullt M, Akerlund T, Bäck E, Odenholt I, Burman LG.

Antimicrob Agents Chemother. 2006 Sep;50(9):3028-32.

18.

Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.

Aspevall O, Lundberg A, Burman LG, Akerlund T, Svenungsson B.

Antimicrob Agents Chemother. 2006 May;50(5):1890-2.

20.

Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions.

Starck J, Källenius G, Marklund BI, Andersson DI, Akerlund T.

Microbiology. 2004 Nov;150(Pt 11):3821-9.

PMID:
15528667
21.

Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Norén T, Akerlund T, Bäck E, Sjöberg L, Persson I, Alriksson I, Burman LG.

J Clin Microbiol. 2004 Aug;42(8):3635-43.

22.

Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile.

Wullt M, Burman LG, Laurell MH, Akerlund T.

J Hosp Infect. 2003 Oct;55(2):124-30.

PMID:
14529637
23.
24.

Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature.

Karlsson S, Dupuy B, Mukherjee K, Norin E, Burman LG, Akerlund T.

Infect Immun. 2003 Apr;71(4):1784-93.

25.

Effects of the Min system on nucleoid segregation in Escherichia coli.

Akerlund T, Gullbrand B, Nordström K.

Microbiology. 2002 Oct;148(Pt 10):3213-22.

PMID:
12368455
26.

Proteins released during high toxin production in Clostridium difficile.

Mukherjee K, Karlsson S, Burman LG, Akerlund T.

Microbiology. 2002 Jul;148(Pt 7):2245-53.

PMID:
12101311
27.

Dynamics of penicillin-susceptible clones in invasive pneumococcal disease.

Henriques Normark B, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, Hedlund J, Svenson SB, Zhou J, Spratt BG, Normark S, Källenius G.

J Infect Dis. 2001 Oct 1;184(7):861-9. Epub 2001 Aug 27.

PMID:
11550126
28.
29.

Clustering of clinical strains of Helicobacter pylori analyzed by two-dimensional gel electrophoresis.

Enroth H, Akerlund T, Sillén A, Engstrand L.

Clin Diagn Lab Immunol. 2000 Mar;7(2):301-6.

30.

On the origin of branches in Escherichia coli.

Gullbrand B, Akerlund T, Nordström K.

J Bacteriol. 1999 Nov;181(21):6607-14.

31.

Analysis of protein synthesis rates after initiation of chromosome replication in Escherichia coli.

Bechtloff D, Grünenfelder B, Akerlund T, Nordström K.

J Bacteriol. 1999 Oct;181(20):6292-9.

32.

Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids.

Karlsson S, Burman LG, Akerlund T.

Microbiology. 1999 Jul;145 ( Pt 7):1683-93.

PMID:
10439407
33.
34.
35.

Branched Escherichia coli cells.

Akerlund T, Nordström K, Bernander R.

Mol Microbiol. 1993 Nov;10(4):849-58.

PMID:
7934847
36.

Cell division in Escherichia coli minB mutants.

Akerlund T, Bernander R, Nordström K.

Mol Microbiol. 1992 Aug;6(15):2073-83.

PMID:
1406249

Supplemental Content

Loading ...
Support Center